Es gab 50 kürzliche Insider-Transaktionen für Cue Biopharma, Inc. (CUE), darunter 44 Käufe und 0 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $7.56M und die gesamten Insider-Verkäufe auf RSU Award.
Bedeutende Insider mit kürzlicher Aktivität umfassen Broadfoot Jill Marie, Kiener Peter A, Morich Frank. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — CUE
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-01-02 |
Broadfoot Jill Marie |
Director |
RSU-Zuteilung |
24,400 |
$0.34 |
$8.3K |
24,400 |
| 2026-01-02 |
Kiener Peter A |
Director |
RSU-Zuteilung |
24,400 |
$0.34 |
$8.3K |
24,400 |
| 2026-01-02 |
Morich Frank |
Director |
RSU-Zuteilung |
24,400 |
$0.34 |
$8.3K |
24,400 |
| 2026-01-02 |
Verheyen Patrick |
Director |
RSU-Zuteilung |
24,400 |
$0.34 |
$8.3K |
24,400 |
| 2026-01-02 |
Garzone Pamela |
Director |
RSU-Zuteilung |
24,400 |
$0.34 |
$8.3K |
24,400 |
| 2026-01-02 |
Sarraf Pasha |
Director |
RSU-Zuteilung |
24,400 |
$0.34 |
$8.3K |
24,400 |
| 2025-12-30 |
Sarraf Pasha |
Director |
Informierter Kauf |
4,229 |
$0.31 |
$1.31K |
4,229 |
| 2025-12-03 |
Sandercock Colin |
SVP, General Counsel |
RSU-Zuteilung |
70,000 |
$0.70 |
$49K |
70,000 |
| 2025-09-29 |
Azam Usman |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-09-29 |
Azam Usman |
Chief Executive Officer |
RSU-Zuteilung |
1,875,000 |
$0.72 |
$1.35M |
1,875,000 |
| 2025-09-29 |
Warren Lucinda |
Chief Business Officer |
RSU-Zuteilung |
125,000 |
$0.72 |
$90K |
125,000 |
| 2025-09-29 |
Baker Daniel G. |
Chief Development Officer |
RSU-Zuteilung |
50,000 |
$0.72 |
$36K |
50,000 |
| 2025-09-26 |
Sandercock Colin |
SVP, General Counsel |
RSU-Zuteilung |
30,000 |
$0.70 |
$21K |
30,000 |
| 2025-06-04 |
Broadfoot Jill Marie |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-06-04 |
Broadfoot Jill Marie |
Director |
RSU-Zuteilung |
48,800 |
$0.62 |
$30.26K |
48,800 |
| 2025-03-21 |
Passeri Daniel R |
Chief Executive Officer |
RSU-Zuteilung |
450,000 |
$0.99 |
$445.5K |
450,000 |
| 2025-03-21 |
Sandercock Colin |
SVP, General Counsel |
RSU-Zuteilung |
200,000 |
$0.99 |
$198K |
200,000 |
| 2025-03-21 |
Millar Kerri-ann |
Chief Financial Officer |
RSU-Zuteilung |
200,000 |
$0.99 |
$198K |
200,000 |
| 2025-03-21 |
Levisetti Matteo |
Chief Medical Officer |
RSU-Zuteilung |
250,000 |
$0.99 |
$247.5K |
250,000 |
| 2025-03-21 |
Warren Lucinda |
Chief Business Officer |
RSU-Zuteilung |
250,000 |
$0.99 |
$247.5K |
250,000 |
| 2025-03-21 |
Baker Daniel G. |
Chief Development Officer |
RSU-Zuteilung |
100,000 |
$0.99 |
$99K |
100,000 |
| 2025-03-10 |
Sarraf Pasha |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-03-10 |
Sarraf Pasha |
Director |
RSU-Zuteilung |
48,800 |
$1.03 |
$50.26K |
48,800 |
| 2025-01-02 |
Driscoll Frederick W |
Director |
RSU-Zuteilung |
24,400 |
$1.09 |
$26.6K |
24,400 |
| 2025-01-02 |
Kiener Peter A |
Director |
RSU-Zuteilung |
24,400 |
$1.09 |
$26.6K |
24,400 |
| 2025-01-02 |
Morich Frank |
Director |
RSU-Zuteilung |
24,400 |
$1.09 |
$26.6K |
24,400 |
| 2025-01-02 |
Verheyen Patrick |
Director |
RSU-Zuteilung |
24,400 |
$1.09 |
$26.6K |
24,400 |
| 2025-01-02 |
Garzone Pamela |
Director |
RSU-Zuteilung |
24,400 |
$1.09 |
$26.6K |
24,400 |
| 2024-12-16 |
Passeri Daniel R |
Chief Executive Officer |
Informierter Kauf |
30,000 |
$1.03 |
$30.9K |
164,578 |
| 2024-11-25 |
Baker Daniel G. |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-11-25 |
Baker Daniel G. |
Chief Development Officer |
RSU-Zuteilung |
200,000 |
$1.06 |
$212K |
200,000 |
| 2024-09-03 |
Warren Lucinda |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2024-09-03 |
Warren Lucinda |
Chief Business Officer |
RSU-Zuteilung |
350,000 |
$0.66 |
$231K |
350,000 |
| 2024-06-05 |
Fox Michael J |
Director |
Unbekannt |
- |
- |
- |
100,000 |
| 2024-06-05 |
Fox Michael J |
Director |
RSU-Zuteilung |
48,800 |
$1.65 |
$80.52K |
48,800 |
| 2024-06-05 |
Sandercock Colin |
SVP, General Counsel |
RSU-Zuteilung |
60,000 |
$1.65 |
$99K |
60,000 |
| 2024-06-05 |
Millar Kerri-ann |
Chief Financial Officer |
RSU-Zuteilung |
60,000 |
$1.65 |
$99K |
60,000 |
| 2024-06-05 |
Suri Anish |
President and CSO |
RSU-Zuteilung |
150,000 |
$1.65 |
$247.5K |
150,000 |
| 2024-06-05 |
Levisetti Matteo |
Chief Medical Officer |
RSU-Zuteilung |
125,000 |
$1.65 |
$206.25K |
125,000 |
| 2024-03-06 |
Passeri Daniel R |
Chief Executive Officer |
RSU-Zuteilung |
400,000 |
$1.94 |
$776K |
400,000 |
| 2024-03-06 |
Sandercock Colin |
SVP, General Counsel |
RSU-Zuteilung |
175,000 |
$1.94 |
$339.5K |
175,000 |
| 2024-03-06 |
Millar Kerri-ann |
Chief Financial Officer |
RSU-Zuteilung |
250,000 |
$1.94 |
$485K |
250,000 |
| 2024-03-06 |
Suri Anish |
President and CSO |
RSU-Zuteilung |
300,000 |
$1.94 |
$582K |
300,000 |
| 2024-03-06 |
Levisetti Matteo |
Chief Medical Officer |
RSU-Zuteilung |
260,000 |
$1.94 |
$504.4K |
260,000 |
| 2024-02-20 |
Levisetti Matteo |
Chief Medical Officer |
RSU-Zuteilung |
25,000 |
$3.36 |
$84K |
25,000 |
| 2024-01-02 |
Driscoll Frederick W |
Director |
RSU-Zuteilung |
24,400 |
$2.78 |
$67.83K |
24,400 |
| 2024-01-02 |
Kiener Peter A |
Director |
RSU-Zuteilung |
24,400 |
$2.78 |
$67.83K |
24,400 |
| 2024-01-02 |
Morich Frank |
Director |
RSU-Zuteilung |
24,400 |
$2.78 |
$67.83K |
24,400 |
| 2024-01-02 |
Verheyen Patrick |
Director |
RSU-Zuteilung |
24,400 |
$2.78 |
$67.83K |
24,400 |
| 2024-01-02 |
Garzone Pamela |
Director |
RSU-Zuteilung |
24,400 |
$2.78 |
$67.83K |
24,400 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
